Receive news by e-mail

#
 

Enter your e-mail in the field below to receive directly the news that appears on this page.

 

topics : related - all Explore

Shopping Categories

  1. 1. Cell Phones
  2. 2. Smartphones
  3. 3. Digital Cameras
  4. 4. Laptop Computers
  5. 5. Processors
  6. 6. Motherboards
  7. 7. LCD Monitors
  8. 8. Graphics Cards
  9. 9. GPS
  10. 10. Digital Camcorders
  11. 11. Printers
  12. 12. Desktop Computers
  13. 13. Sedans
  14. 14. Coupes & Convertibles
  15. 15. 4x4

Wikio Shopping

  1. 1. Automotive
  2. 2. Beauty & Fragrances
  3. 3. Books
  4. 4. Car/Motorbike
  5. 5. CD
  6. 6. Clothing, Accessories & Shoes
  7. 7. Communication
  8. 8. Computers
  9. 9. DVD
  10. 10. Electronics
  11. 11. Flowers & Gifts
  12. 12. Gourmet & Foods
  13. 13. Health & Personal Care
  14. 14. Home & Garden
  15. 15. Hotels
  16. 16. Household Appliances
  17. 17. Jewelry & Watches
  18. 18. Musical Instruments
  19. 19. Sports & Outdoors
  20. 20. Toys & Baby
  21. 21. Video Games

Participate



Novavax Inc.



Sort by : relevance - date
5Vote!

Novavax Reports Third Quarter 2009 Financial Results

[NEWS] ROCKVILLE, Md., Nov. 6 /PRNewswire-FirstCall/ — Novavax, Inc. (Nasdaq: NVAX) today announced financial results for the third quarter ended September 30, 2009 and reviewed its recent accomplishments and upcoming milestones. Novavax's net loss for the third quarter of 2009 was $7.5 million, or $0.08 per share, compared to a net loss of $7.8 million, or $0.12 per share,...

6Vote!

Novavax Reports Third Quarter 2009 Financial Results

ROCKVILLE, Md., Nov. 6 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced financial results for the third quarter ended September 30, 2009 and reviewed its recent accomplishments and upcoming milestones.

3Vote!

Novavax Reports Positive Data For Its Trivalent Seasonal Influenza (VLP) Vaccine Candidate In A Second Phase II Study

Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced that the Company made a poster presentation on the "Safety and Immunogenicity of a Recombinant Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine in Healthy Adults" on Saturday, October 31, 2009 at the 47(th) Annual Meeting of the Infectious Diseases Society of America (IDSA).

4Vote!

Novavax seasonal flu vaccine meets study goal

Biotechnology company Novavax Inc. said Monday its seasonal flu vaccine candidate met key goals in a midstage clinical trial.

5Vote!

Novavax seasonal flu vaccine meets study goal

ROCKVILLE, Md. -- Biotechnology company Novavax Inc. said Monday its seasonal flu vaccine candidate met key goals in a midstage clinical trial.

7Vote!

Novavax seasonal flu vaccine meets study goal

Biotechnology company Novavax Inc. said Monday its seasonal flu vaccine candidate met key goals in a midstage clinical trial.

4Vote!

Novavax Reports Positive Data for its Trivalent Seasonal Influenza (VLP) Vaccine Candidate in a Second Phase II Study

ROCKVILLE, Md., Nov. 2 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that the Company made a poster presentation on the "Safety and Immunogenicity of a Recombinant Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine in Healthy Adults" on Saturday, October 31, 2009 at the 47(th) Annual Meeting of the Infectious...

5Vote!

Novavax seasonal flu vaccine meets study goal

(11-02) 06:59 PST Rockville, Md. (AP) -- Biotechnology company Novavax Inc. said Monday its seasonal flu vaccine candidate met key goals in a midstage clinical trial. The company said it presented the results at the 47th annual meeting of the... Clinical trial - Flu season - Health - Influenza - Vaccination

4Vote!

Pre Market Stock Gainers - 11/5/09

Below is a list of some of the largest stock gainers and losers so far in pre market for November 5, 2009. Check out my Hot Stocks to Watch page for the latest updates. Pre Market Stock Gainers - 11/5/09 Sunesis Pharmaceuticals Inc. (SNSS) - Sunesis' Voreloxin Receives FDA Orphan Drug Designation for Acute Myeloid Leukemia Parlux Fragrances Inc. (PARL) - Parlux Q2 profit falls ; sees...